122 related articles for article (PubMed ID: 3821915)
1. Radioimmunodetection of human melanoma with indium-111-labeled monoclonal antibodies.
Taylor A; Milton W; Eyre H; Wu FP; Christian P; Alazraki N; Datz F; Unger MW
NCI Monogr; 1987; (3):25-31. PubMed ID: 3821915
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunodetection of human melanoma with indium-111-labeled monoclonal antibody.
Taylor A; Milton W; Eyre HP; Christian P; Wu F; Hagan P; Alazraki N; Datz FL; Unger M
J Nucl Med; 1988 Mar; 29(3):329-37. PubMed ID: 3346743
[TBL] [Abstract][Full Text] [Related]
3. Scintigraphic detection of metastatic melanoma using indium 111/DTPA conjugated anti-gp240 antibody (ZME-018).
Kirkwood JM; Neumann RD; Zoghbi SS; Ernstoff MS; Cornelius EA; Shaw C; Ziyadeh T; Fine JA; Unger MW
J Clin Oncol; 1987 Aug; 5(8):1247-55. PubMed ID: 3625247
[TBL] [Abstract][Full Text] [Related]
4. Immunoreactivity and biodistribution of indium-111-labeled monoclonal antibody to a human high molecular weight-melanoma associated antigen.
Fawwaz RA; Wang TS; Estabrook A; Rosen JM; Hardy MA; Alderson PO; Srivastava SC; Richards P; Ferrone S
J Nucl Med; 1985 May; 26(5):488-92. PubMed ID: 3989605
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunoimaging in malignant melanoma with 111In-labeled monoclonal antibody 96.5.
Murray JL; Rosenblum MG; Sobol RE; Bartholomew RM; Plager CE; Haynie TP; Jahns MF; Glenn HJ; Lamki L; Benjamin RS
Cancer Res; 1985 May; 45(5):2376-81. PubMed ID: 3986779
[TBL] [Abstract][Full Text] [Related]
6. Effect of antibody dose on the imaging and biodistribution of indium-111 9.2.27 anti-melanoma monoclonal antibody.
Carrasquillo JA; Abrams PG; Schroff RW; Reynolds JC; Woodhouse CS; Morgan AC; Keenan AM; Foon KA; Perentesis P; Marshall S
J Nucl Med; 1988 Jan; 29(1):39-47. PubMed ID: 3335926
[TBL] [Abstract][Full Text] [Related]
7. Radioimmunoimaging in malignant melanoma patients with the use of indium-111-labeled antimelanoma monoclonal antibody (ZME-018) to high-molecular-weight antigen.
Murray JL; Rosenblum MG; Lamki L; Haynie TP; Glenn HJ; Plager CE; Unger MW; Carlo DJ; Hersh EM
NCI Monogr; 1987; (3):3-9. PubMed ID: 3821916
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunodetection of melanoma utilizing In-111 96.5 monoclonal antibody: a preliminary report.
Halpern SE; Dillman RO; Witztum KF; Shega JF; Hagan PL; Burrows WM; Dillman JB; Clutter ML; Sobol RE; Frincke JM
Radiology; 1985 May; 155(2):493-9. PubMed ID: 3983401
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of 111In-labeled anti-p97 monoclonal antibody in patients with metastatic malignant melanoma.
Rosenblum MG; Murray JL; Haynie TP; Glenn HJ; Jahns MF; Benjamin RS; Frincke JM; Carlo DJ; Hersh EM
Cancer Res; 1985 May; 45(5):2382-6. PubMed ID: 3986780
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody imaging of human melanoma. Radioimmunodetection by subcutaneous or systemic injection.
Lotze MT; Carrasquillo JA; Weinstein JN; Bryant GJ; Perentesis P; Reynolds JC; Matis LA; Eger RR; Keenan AM; Hellström I
Ann Surg; 1986 Sep; 204(3):223-35. PubMed ID: 3753057
[TBL] [Abstract][Full Text] [Related]
11. Clinical parameters related to optimal tumor localization of indium-111-labeled mouse antimelanoma monoclonal antibody ZME-018.
Murray JL; Rosenblum MG; Lamki L; Glenn HJ; Krizan Z; Hersh EM; Plager CE; Bartholomew RM; Unger MW; Carlo DJ
J Nucl Med; 1987 Jan; 28(1):25-33. PubMed ID: 3794809
[TBL] [Abstract][Full Text] [Related]
12. Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial.
Scott AM; Lee FT; Hopkins W; Cebon JS; Wheatley JM; Liu Z; Smyth FE; Murone C; Sturrock S; MacGregor D; Hanai N; Inoue K; Yamasaki M; Brechbiel MW; Davis ID; Murphy R; Hannah A; Lim-Joon M; Chan T; Chong G; Ritter G; Hoffman EW; Burgess AW; Old LJ
J Clin Oncol; 2001 Oct; 19(19):3976-87. PubMed ID: 11579119
[TBL] [Abstract][Full Text] [Related]
13. Comparison of gallium-67 versus indium-111 monoclonal antibody (96.5, ZME-018) in detection of human melanoma in athymic mice.
Chan SM; Hoffer PB; Maric N; Zoghbi SS; Kirkwood JM; Ernstoff MS; Duray PH; Gerich B
J Nucl Med; 1987 Sep; 28(9):1441-6. PubMed ID: 3476691
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.
Wong JY; Thomas GE; Yamauchi D; Williams LE; Odom-Maryon TL; Liu A; Esteban JM; Neumaier M; Dresse S; Wu AM; Primus FJ; Shively JE; Raubitschek AA
J Nucl Med; 1997 Dec; 38(12):1951-9. PubMed ID: 9430476
[TBL] [Abstract][Full Text] [Related]
15. Radioimmunodetection of malignant melanoma with the 225.28S monoclonal antibody to HMW-MAA.
Buraggi GL
Nuklearmedizin; 1986 Dec; 25(6):220-4. PubMed ID: 3808962
[TBL] [Abstract][Full Text] [Related]
16. Sequential use of indium-111 labeled monoclonal antibodies 96.5 and ZME-018 does not increase detection sensitivity for metastatic melanoma.
Frontiera M; Murray JL; Lamki L; Thomas J; Satterlee W; Schmelter R; Rosenblum MG; Khazaeli MB; Unger MW; Robinson WA
Clin Nucl Med; 1989 May; 14(5):357-66. PubMed ID: 2656042
[TBL] [Abstract][Full Text] [Related]
17. Immunospecific saturable clearance mechanisms for indium-111-labeled anti-melanoma monoclonal antibody 96.5 in humans.
Murray JL; Lamki LM; Shanken LJ; Blake ME; Plager CE; Benjamin RS; Schweighardt S; Unger MW; Rosenblum MG
Cancer Res; 1988 Aug; 48(15):4417-22. PubMed ID: 3390837
[TBL] [Abstract][Full Text] [Related]
18. Kinetic model for the biodistribution of an 111In-labeled monoclonal antibody in humans.
Eger RR; Covell DG; Carrasquillo JA; Abrams PG; Foon KA; Reynolds JC; Schroff RW; Morgan AC; Larson SM; Weinstein JN
Cancer Res; 1987 Jun; 47(12):3328-36. PubMed ID: 3581071
[TBL] [Abstract][Full Text] [Related]
19. Targeting of indium 111-labeled bivalent hapten to human melanoma mediated by bispecific monoclonal antibody conjugates: imaging of tumors hosted in nude mice.
Le Doussal JM; Gruaz-Guyon A; Martin M; Gautherot E; Delaage M; Barbet J
Cancer Res; 1990 Jun; 50(11):3445-52. PubMed ID: 2334941
[TBL] [Abstract][Full Text] [Related]
20. Phase 1 immunolymphoscintigraphy with an In-111-labeled antimelanoma monoclonal antibody.
Engelstad BL; Spitler LE; Del Rio MJ; Ramos EC; Rosendorf LL; Reinhold CE; Khentigan A; Huberty JP; Corpuz SW; Lee HM
Radiology; 1986 Nov; 161(2):419-22. PubMed ID: 3763912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
